Series Editor:
Harry Brittain, Center for Pharmaceutical Physics, Milford, NJ, USA
Description
Although the official compendia define a drug substance as to identity, purity, strength, and quality, they normally do not provide other
physical or chemical data, nor do they list methods of synthesis or pathways of physical or biological degradation and metabolism. Such
information is scattered throughout the scientific literature and the files of pharmaceutical laboratories.
Edited by the Associate
Director of Analytical Research and Development for the American Association of Pharmaceutical Scientists,
Analytical Profiles
of Drug Substances and Excipients brings this information together in one source. The scope of the series has recently been
expanded to include profiles of excipient materials.
Included in series
Profiles of Drug Substances, Excipients and Related Methodology
Audience:
Analytical, pharmaceutical, and medicinal chemists and pharmacologists
